Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators.
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
Pathophysiology of Hepatorenal Syndrome.
Velez JCQ, Latt N, Rodby RA.
Adv Kidney Dis Health. 2024 Mar;31(2):87-99. doi: 10.1053/j.akdh.2024.01.002.
News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR.
J Hepatol. 2019 Oct;71(4):811-822. doi: 10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11.
Hepatorenal syndrome.
Angeli P, Morando F, Cavallin M, Piano S.
Contrib Nephrol. 2011;174:46-55. doi: 10.1159/000329235. Epub 2011 Sep 9.
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K.
J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7.
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.
Iwakiri Y, Trebicka J.
JHEP Rep. 2021 Jun 4;3(4):100316. doi: 10.1016/j.jhepr.2021.100316. eCollection 2021 Aug.
The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.
Pitre T, Kiflen M, Helmeczi W, Dionne JC, Rewa O, Bagshaw SM, Needham-Nethercott N, Alhazzani W, Zeraatkar D, Rochwerg B.
Crit Care Med. 2022 Oct 1;50(10):1419-1429. doi: 10.1097/CCM.0000000000005595. Epub 2022 Sep 12.
Hepatorenal syndrome and type 1 and 2 cardiorenal syndromes: distinct competing medical therapies applied to a similar background of vasomotor reactive nephropathy.
De Vecchis R, Esposito C, Di Biase G, Ariano C.
Minerva Cardioangiol. 2014 Feb;62(1):105-16.
Hepatorenal syndrome.
Lata J.
World J Gastroenterol. 2012 Sep 28;18(36):4978-84. doi: 10.3748/wjg.v18.i36.4978.
Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?
Angeli P, Piano S.
Liver Transpl. 2015 Nov;21(11):1335-7. doi: 10.1002/lt.24339.
